Group 1 - The core viewpoint of the article highlights that Yongxi Investment has conducted research on a listed company, Weili Medical, focusing on its strategies to expand overseas production in response to domestic medical consumables procurement and geopolitical risks [1] - Weili Medical is actively building a factory in Mexico starting in 2024, having completed land acquisition and project planning, while also preparing a second overseas production base in Indonesia to mitigate high tariffs imposed by the U.S. [1] - The company expects that by 2024, overseas business will account for approximately 54% of its total revenue, with North America contributing 34%, Europe 27%, Asia 15%, and South America 8% [1] Group 2 - Weili Medical has seen a significant increase in the gross profit margin of its overseas business, rising from 27% in 2021 to 35% in 2024, an increase of 8 percentage points [1] - The company is diversifying its export products, with a growing proportion of high-margin products being exported, which contributes to the overall improvement in gross profit margins [1]

Core Viewpoint - The recent adjustments in U.S.-China tariffs have led to a surge in production and export activities among toy manufacturers in Chaozhou, Guangdong, as they aim to capitalize on a 90-day window to ship goods before potential tariff re-implementation [1][4]. Group 1: Impact of Tariff Adjustments - The U.S. has canceled 91% of additional tariffs on Chinese goods and suspended 24% of tariffs for 90 days, prompting manufacturers to expedite shipments [1]. - Many toy manufacturers, including Weili Intelligent Technology Co., have resumed production and shipping after previously facing order delays due to high tariffs [2][4]. - The toy industry in Chaozhou typically sees a peak in exports from April to October, but the imposition of tariffs in April caused significant disruptions [2][3]. Group 2: Production and Order Fulfillment - Weili Intelligent reported a full production schedule, with orders extending into September as they work to fulfill delayed shipments [4]. - Other companies, such as Daya Plastic Toys Co., have also resumed production and are receiving new orders from U.S. clients [4]. - Blue Light Electronics Technology Co. noted a 30% increase in order volume compared to pre-tariff levels, indicating a recovery in business activity [5]. Group 3: Strategic Adjustments and Future Planning - Companies are exploring overseas production options in Southeast Asia to mitigate the impact of tariffs, with some already establishing factories in countries like Vietnam [6][7]. - Despite the tariff relief, the cost of exporting from China remains higher compared to Southeast Asian countries, prompting companies to consider diversifying their production locations [6][7]. - The efficiency of production in Southeast Asia is perceived to be lower than in China, which may limit the extent of production relocation [7].